Study ID: CTSU C90601
Description:

Randomized Double-Blind Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma

Location:
Sioux Falls Region,Fargo Region,Bismarck Region,Bemidji Clinic
Principal Investigator:
Miroslaw Mazurczak MD,Preston Steen MD
Disease:
Bladder
Stage:
Phase III

Status:

Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.

Back to Clinical Trials list